Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04239976 · ClinicalTrials.gov registry record · NA
Scrambler Therapy for the Reduction of Chemotherapy-Induced Neuropathic Pain
A NA study of Malignant Neoplasm and Chemotherapy-induced Peripheral Neuropathy, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT04239976 is a NA study of Malignant Neoplasm and Chemotherapy-induced Peripheral Neuropathy that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 16 participants, below the 513-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04239976, a NA study of Malignant Neoplasm and Chemotherapy-induced Peripheral Neuropathy, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies how well scrambler therapy works in reducing chemotherapy-induced neuropathic pain in patients with cancer. Scrambler therapy is a type of treatment that uses electrodes placed on the skin. Electricity is carried from the electrodes through the skin and blocks the pain.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- DEVICE FitBit
- OTHER Gait Assessment Test
- OTHER MC5-A Scrambler Therapy
- PROCEDURE Quantitative Sensory Testing
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2019-04-04 |
| Est. Completion | 2022-03-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04239976
The ClinicalTrials.gov registry entry for NCT04239976 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 513-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (97% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Malignant Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04239976 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04239976 about?
NCT04239976 is a clinical study titled "Scrambler Therapy for the Reduction of Chemotherapy-Induced Neuropathic Pain". This trial studies how well scrambler therapy works in reducing chemotherapy-induced neuropathic pain in patients with cancer. Scrambler therapy is a type of treatment that uses electrodes placed on the skin. Electricity is carried from the electrodes through the skin and blocks the pain.
What is the current status of trial NCT04239976?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2019-04-04. Estimated completion is 2022-03-18.
What conditions does trial NCT04239976 study?
This clinical trial studies the following conditions: Malignant Neoplasm, Chemotherapy-induced Peripheral Neuropathy.
What interventions are being tested in trial NCT04239976?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), FitBit (DEVICE), Gait Assessment Test (OTHER), MC5-A Scrambler Therapy (OTHER), Quantitative Sensory Testing (PROCEDURE).
Who is sponsoring clinical trial NCT04239976?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04239976 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
RECRUITING · NA
-
Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials
RECRUITING · NA
-
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
RECRUITING · NA
-
Decreasing Chemotherapy Induced Distress Using Immersive Virtual Reality in Patients With Cancer
RECRUITING · NA
-
A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant
RECRUITING · NA
-
Reproductive Health Program in Patients With Cancer
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.